Bluebird Bio Financials
| BLUEDelisted Stock | USD 4.97 0.23 4.85% |
Bluebird |
Understanding current and past Bluebird Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bluebird Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Bluebird Bio's assets may result in an increase in income on the income statement.
Please note, the presentation of Bluebird Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bluebird Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Bluebird Bio's management manipulating its earnings.
Bluebird Bio Stock Summary
Bluebird Bio competes with Mersana Therapeutics, Zentalis Pharmaceuticals, Y MAbs, Travere Therapeutics, and Madrigal Pharmaceuticals. bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts. Bluebird Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 518 people.| Foreign Associate | Canada |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US09609G2093 |
| Business Address | 455 Grand Union |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.bluebirdbio.com |
| Phone | 339 499 9300 |
| Currency | USD - US Dollar |
Bluebird Bio Key Financial Ratios
Bluebird Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bluebird Bio's current stock value. Our valuation model uses many indicators to compare Bluebird Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bluebird Bio competition to find correlations between indicators driving Bluebird Bio's intrinsic value. More Info.Bluebird Bio is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Bluebird Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Bluebird Bio Market Pulse
| Quote | 4.97 |
| Change(%) | 4.85 |
| Change | 0.23 |
| Open | 4.74 |
| Low | 4.67 |
| High | 5.03 |
| Volume | 0 |
| Exchange | NASDAQ |
About Bluebird Bio Financials
What exactly are Bluebird Bio Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Bluebird Bio's income statement, its balance sheet, and the statement of cash flows. Potential Bluebird Bio investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Bluebird Bio investors may use each financial statement separately, they are all related. The changes in Bluebird Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bluebird Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Bluebird Bio July 21, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Bluebird Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bluebird Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bluebird Bio based on widely used predictive technical indicators. In general, we focus on analyzing Bluebird Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bluebird Bio's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.64 | |||
| Information Ratio | 0.0629 | |||
| Maximum Drawdown | 50.85 | |||
| Value At Risk | (6.00) | |||
| Potential Upside | 10.28 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Bluebird Stock
If you are still planning to invest in Bluebird Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bluebird Bio's history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |